Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.

However, we found a biologically plausible association between administration of an anti-CD20 monoclonal antibody within 12 months prior to vaccination and lack of antibody response, though this did not reach statistical significance ( Table 1 ).

also in 111,027 other papers